Scifiniti Publishing is pleased to announce the launch of its new peer-reviewed, open-access journal, Organic and Medicinal Chemistry Connect, which focuses on the interface of organic synthesis, medicinal chemistry, and translational drug discovery.

The journal provides a platform for scientists in academia, biotechnology, and pharmaceutical industries to share advances that support innovation in the discovery of therapeutics addressing unmet medical needs. Organic and Medicinal Chemistry Connect follows a continuous publication model and is licensed under Creative Commons Attribution 4.0 (CC BY 4.0).

The journal is led by Dr. Taleb AlTel as, Editor-in-Chief, who also serves as Chief Scientific Officer and Director of Medicinal Chemistry at Manglovo Health, New York, USA. With his expertise, he will guide the journal in maintaining high-quality publications that integrate chemistry and biology for therapeutic applications.

The journal aims to:

• Connect the disciplines of organic chemistry, chemical biology, and medicinal chemistry to support the discovery of novel bioactive molecules.
• Promote innovation in drug design through the integration of synthetic chemistry, molecular modeling, chemoproteomics, and target-based pharmacology.
• Provide a forum for rapid communication of high-impact findings through research letters, communications, and perspectives.
• Highlight emerging areas such as covalent inhibitors, mono- and bivalent molecular glues, and targeted protein degradation that advance modern drug discovery approaches.
• Encourage interdisciplinary and translational research linking chemical innovation to biological function and therapeutic application.

We warmly invite researchers, authors, reviewers, and editors to contribute and participate in publishing high-quality research. For more details, please visit: https://scifiniti.com/journals/organic-medicinal-chemistry-connect